Innocan Pharma (INNPF) EBT Margin (2024 - 2025)
Innocan Pharma's EBT Margin was 31.94% in the quarter ended Dec 31, 2025, up 31.88 percentage points from 0.06% a year earlier and up 52.93 percentage points from the prior quarter.
Powered by 
Analysis
Innocan Pharma (INNPF) EBT Margin (2024 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, EBT Margin at Innocan Pharma came in at 0.32%, down 2.80 percentage points from the prior year.
- In earlier years, EBT Margin was 3.12% in the year ended Dec 31, 2024 (+32.66 pp) and -29.54% in the year ended Dec 31, 2023.
- The figure for the quarter ended Dec 31, 2025 marks the highest quarterly EBT Margin in data going back to the quarter ended Mar 31, 2024.
- Compared with a year earlier, EBT Margin was higher in two of the last four quarters, with an average year-over-year change of +0.76 percentage points.
- Per Business Quant data, INNPF's EBT Margin in the three quarters before the quarter ended Dec 31, 2025 was -20.99% (quarter ended Sep 30, 2025), -1.56% (quarter ended Jun 30, 2025) and 0.42% (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 20.41% |
| 10 | Innocan Pharma | 5.78 Mn | 1.73 Mn | 4.43 Mn | 31.94% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 31.94% |
| Sep 30, 2025 | -20.99% |
| Jun 30, 2025 | -1.56% |
| Mar 31, 2025 | 0.42% |
| Dec 31, 2024 | 0.06% |
| Sep 30, 2024 | 8.14% |
| Jun 30, 2024 | 16.59% |
| Mar 31, 2024 | -18.03% |
API Access
Innocan Pharma EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=INNPF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "INNPF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=INNPF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();